Atrial fibrillation: strategies to control, combat, and cure (Q34544936)

2 August 2017

1 reference

title

Atrial fibrillation: strategies to control, combat, and cure (English)

1 reference

2 August 2017

0 references

3

Prapa Kanagaratnam

1 reference

2 August 2017

Nicholas S Peters

1

1 reference

2 August 2017

Richard J Schilling

series ordinal

2

1 reference

2 August 2017

Vias Markides

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

volume

359

1 reference

2 August 2017

issue

9306

1 reference

2 August 2017

page(s)

593-603

1 reference

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

1 reference

7 January 2021

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left V

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Clinical features of paroxysmal atrial fibrillation an observation of 94 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Computerized Global Electrophysiological Mapping of the Atrium in Patients with Wolft-Parkinson-White Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

High-density mapping of electrically induced atrial fibrillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Epicardial right atrial free wall mapping in chronic atrial fibrillation. Documentation of repetitive activation with a focal spread--a hitherto unrecognised phenomenon in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Endocardial mapping of atrial fibrillation in the human right atrium using a non-contact catheter.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Ionic mechanisms of electrical remodeling in human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

The natural history of lone atrial fibrillation. A population-based study over three decades

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Are electrophysiological changes induced by longer lasting atrial fibrillation reversible? :observations using the atrial defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Initiation of atrial fibrillation by ectopic beats originating from the superior vena cava: electrophysiological characteristics and results of radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Idiopathic paroxysmal atrial fibrillation induced by a focal discharge mechanism in the left superior pulmonary vein: possible roles of the ligament of Marshall

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Identification of a genetic locus for familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Genetics of cardiovascular disease with emphasis on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Effect of an irregular ventricular rhythm on cardiac output

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Incidence of and risk factors for atrial fibrillation in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Functional capacity before and after cardioversion of atrial fibrillation: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Initial energy for elective external cardioversion of persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Low energy intracardiac cardioversion of persistent atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

The Interaction of Antiarrhythmic Drugs and the Energy for Cardioversion of Chronic Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

1 reference

7 January 2021

Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Usefulness of propafenone for recurrent paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Amiodarone for refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Randomized prospective pilot study of long-term dual-site atrial pacing for prevention of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

No incremental benefit of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

A new pacing algorithm for overdrive suppression of atrial fibrillation. Chorus Multicentre Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Prevention of atrial arrhythmias during DDD pacing by atrial overdrive.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Comparison of the acute effects of pacing the atrial septum, right atrial appendage, coronary sinus os, and the latter two sites simultaneously on the duration of atrial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Ablation of right and left ectopic atrial tachycardias using a three-dimensional nonfluoroscopic mapping system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Five-year experience with the maze procedure for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Current status of the Maze procedure for the treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Results of maze surgery for lone paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Effects of the maze operation on health-related quality of life in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Inefficacy of “therapeutic” serum levels of digoxin in controlling the ventricular rate in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis--a randomised cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Intravenous amiodarone bolus immediately controls heart rate in patients with atrial fibrillation accompanied by severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Embolic complications in paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Risk of stroke in non-rheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907748-6

7 January 2021

10.1016/S0140-6736(02)07748-6

Identifiers

DOI

1 reference

2 August 2017

1 reference